ClinicalTrials.gg
Sign In

Intraocular Lymphoma clinical trials

The registry lists 165 studies for Intraocular Lymphoma across more than 10 countries. 9 are recruiting or about to start. 17 of them are mainly about Intraocular Lymphoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Intraocular Lymphoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
109
Terminated
24
Withdrawn
10
Status unknown
9
Recruiting
6
Active, not recruiting
4

Phase

Phase 1
75
Phase 2
40
Phase 3
14
Early Phase 1
3

Where

United States
130
Italy
9
Germany
8
Canada
6
France
5
Switzerland
4

Who runs them

National Cancer Institute (NCI) (32) · Fred Hutchinson Cancer Center (14) · City of Hope Medical Center (6) · Memorial Sloan Kettering Cancer Center (6) · Barbara Ann Karmanos Cancer Institute (5) · Case Comprehensive Cancer Center (5) · Northwestern University (4) · Wake Forest University Health Sciences (4)

What is being tested here

Drugs under test in Intraocular Lymphoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rituximab2012
Methotrexate207
Lenalidomide106
Atropine101
Zanubrutinib101
Ascorbic Acid101
Cyclophosphamide0110
Fludarabine phosphate018
Fludarabine018
Etoposide016

Drug classes tested here Antimetabolites 2 open · Tyrosine kinase inhibitors (TKIs) 1 open · Alkylating agents 16 · Calcineurin inhibitors 9 · HDAC inhibitors 8

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 6 Intraocular Lymphoma studies recruiting now, 3 (50%) set no upper age limit and 2 (33%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
184 (67%)4 (67%)
304 (67%)4 (67%)
404 (67%)4 (67%)
504 (67%)4 (67%)
656 (100%)6 (100%)
756 (100%)6 (100%)
854 (67%)4 (67%)

Across all 165 studies, recruiting or not: 25% stop at 75 or younger and 13% at 65; 28% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Intraocular Lymphoma studies take

Of 10 phase 1 interventional studies under Intraocular Lymphoma, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 139 mo37–71 · 10 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 165. Browse all 165 → or search them.